Significant emphasis has been placed recently on designing more effective fluorouracil (5-FU)-based combination protocols for gastrointestinal cancer. Promising results were seen with 5-FU/leucovorin in combination with
Udo Vanhoefer, MD
Advertisement
Articles by Udo Vanhoefer, MD
Advertisement
Latest Updated Articles
- Oral Fluoropyrimidine-Based Combination Therapy in Gastrointestinal Cancer
Published: January 2nd 2001 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Tarlatamab Plus Chemo/IO Regimens Are Safe, Elicit Responses in ES-SCLC
2
Frontline Alectinib Upholds OS Benefit in Advanced ALK+ NSCLC
3
Tarlatamab Improves Survival Vs Chemotherapy in Second-Line SCLC Subgroups
4
Episode 16: Anticipated ESMO 2025 Data That May Change GU Oncology
5
